SCHEMBL6342180

SCHEMBL6342180

Clc1ccc(Cl)c(-n2ccnc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.70
NOTUM Q6P988 1/20 0.56
CYP3A4 P08684 5/20 0.47
CYP2D6 P10635 4/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
LMNA P02545 2/20 0.47
CGAS Q8N884 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
PMP22 Q01453 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ADRA2C P18825 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6334824 0.85 IDO1 (0.65) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL29084862 0.82 IDO1 (1.00) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL9451269 0.82 IDO1 (0.57) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL23486498 0.79 IDO1 (0.76) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL29758190 0.79 IDO1 (0.76) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL30702138 0.79 IDO1 (0.61) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL20360005 0.79 IDO1 (0.61) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL16983194 0.79 IDO1 (0.61) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL9451220 0.78 CYP11B1 (0.57) IDO1NOTUMCYP3A4CYP2D6CYP1A2
SCHEMBL11702033 0.78 IDO1 (0.60) IDO1NOTUMCYP3A4CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105873900-A Process for diazotizing 2, 5-dichloroaniline 孟山都技术公司 2016-08-17 CN disclosed
US-6960601-B2 Preparation and use of imidazole derivatives for treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2005-11-01 US disclosed